These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Longitudinal study of the levodopa motor response in Parkinson's disease: relationship between cognitive decline and motor function. Alty JE, Clissold BG, McColl CD, Reardon KA, Shiff M, Kempster PA. Mov Disord; 2009 Dec 15; 24(16):2337-43. PubMed ID: 19890972 [Abstract] [Full Text] [Related]
4. Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease. McColl CD, Reardon KA, Shiff M, Kempster PA. Mov Disord; 2002 Nov 15; 17(6):1227-34. PubMed ID: 12465061 [Abstract] [Full Text] [Related]
6. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Fasano A, Romito LM, Daniele A, Piano C, Zinno M, Bentivoglio AR, Albanese A. Brain; 2010 Sep 15; 133(9):2664-76. PubMed ID: 20802207 [Abstract] [Full Text] [Related]
8. Study of levodopa response in Parkinson's disease: Observations on rates of motor progression. Ding C, Ganesvaran G, Alty JE, Clissold BG, McColl CD, Reardon KA, Schiff M, Srikanth V, Kempster PA. Mov Disord; 2016 Apr 15; 31(4):589-92. PubMed ID: 26873476 [Abstract] [Full Text] [Related]
10. Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation. Wider C, Russmann H, Villemure JG, Robert B, Bogousslavsky J, Burkhard PR, Vingerhoets FJ. Arch Neurol; 2006 Jul 15; 63(7):951-5. PubMed ID: 16831963 [Abstract] [Full Text] [Related]
11. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Merola A, Zibetti M, Angrisano S, Rizzi L, Ricchi V, Artusi CA, Lanotte M, Rizzone MG, Lopiano L. Brain; 2011 Jul 15; 134(Pt 7):2074-84. PubMed ID: 21666262 [Abstract] [Full Text] [Related]
12. When do levodopa motor fluctuations first appear in Parkinson's disease? Stocchi F, Jenner P, Obeso JA. Eur Neurol; 2010 Jul 15; 63(5):257-66. PubMed ID: 20332641 [Abstract] [Full Text] [Related]
14. Levodopa induced motor complications in Thai Parkinson's disease patients. Kulkantrakorn K, Tiamkao S, Pongchaiyakul C, Pulkes T. J Med Assoc Thai; 2006 May 15; 89(5):632-7. PubMed ID: 16756048 [Abstract] [Full Text] [Related]
15. Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease. Olanow CW, Kieburtz K, Stern M, Watts R, Langston JW, Guarnieri M, Hubble J, US01 Study Team. Arch Neurol; 2004 Oct 15; 61(10):1563-8. PubMed ID: 15477510 [Abstract] [Full Text] [Related]
18. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease. Bäumer T, Hidding U, Hamel W, Buhmann C, Moll CK, Gerloff C, Orth M, Siebner HR, Münchau A. Mov Disord; 2009 Apr 15; 24(5):672-6. PubMed ID: 19185021 [Abstract] [Full Text] [Related]
19. Lack of motor symptoms progression in Parkinson's disease patients with long-term bilateral subthalamic deep brain stimulation. Tagliati M, Martin C, Alterman R. Int J Neurosci; 2010 Nov 15; 120(11):717-23. PubMed ID: 20942586 [Abstract] [Full Text] [Related]